相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CD74 Is a Novel Prognostic Factor for Patients with Pancreatic Cancer Receiving Multimodal Therapy
Shigenori Nagata et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer
Eva Verjans et al.
BMC CANCER (2009)
Combining Milatuzumab with Bortezomib, Doxorubicin, or Dexamethasone Improves Responses in Multiple Myeloma Cell Lines
Rhona Stein et al.
CLINICAL CANCER RESEARCH (2009)
Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas
R. J. Cuthbert et al.
EUROPEAN JOURNAL OF CANCER (2009)
A functional heteromeric MIF receptor formed by CD74 and CXCR4
Verena Schwartz et al.
FEBS LETTERS (2009)
Overexpression of the Fas-inhibitory molecule TOSO-a novel antiapoptotic factor in chronic lymphocytic leukemia
Christian Philipp Pallasch et al.
LEUKEMIA & LYMPHOMA (2009)
CD74 in antigen presentation, inflammation, and cancers of the gastrointestinal tract
Ellen J. Beswick et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Macrophage CD74 contributes to MIF-induced pulmonary inflammation
Koichiro Takahashi et al.
RESPIRATORY RESEARCH (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
Edward J. Miller et al.
NATURE (2008)
Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex
Yael Gore et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CD74 induces TAp63 expression leading to B-cell survival
Frida Lantner et al.
BLOOD (2007)
CD74: A new candidate target for the immunotherapy of B-Cell neoplasms
Rhona Stein et al.
CLINICAL CANCER RESEARCH (2007)
IL-8 secreted in a macrophage migration-inhibitory factor- and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival
Inbal Binsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity
H. Lue et al.
ONCOGENE (2007)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells
Katherine L. Meyer-Siegler et al.
JOURNAL OF IMMUNOLOGY (2006)
CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex
Xuerong Shi et al.
IMMUNITY (2006)
International uniform response criteria for multiple myeloma
B. G. M. Durie et al.
LEUKEMIA (2006)
Cell-surface CD74 initiates a signaling cascade leading to cell proliferation and survival
Diana Starlets et al.
BLOOD (2006)
Helicobacter pylori CagA-dependent macrophage migration inhibitory factor produced by gastric epithelial cells binds to CD74 and stimulates procarcinogenic events
Ellen J. Beswick et al.
JOURNAL OF IMMUNOLOGY (2006)
Invariant chain transmembrane domain trimerization: A step in MHC class II assembly
AM Dixon et al.
BIOCHEMISTRY (2006)
Establishment of perineural invasion models and analysis of gene expression revealed an invariant chain (CD74) as a possible molecule involved in perineural invasion in pancreatic cancer
N Koide et al.
CLINICAL CANCER RESEARCH (2006)
Effective therapy of human lymphoma xenografts with a novel recombinant ribonuclease/anti-CD74 humanized IgG4 antibody immunotoxin
CH Chang et al.
BLOOD (2005)
Polarized expression of CD74 by gastric epithelial cells
CA Barrera et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2005)
CD74 is a member of the regulated intramembrane proteolysis-processed protein family
S Becker-Herman et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys
P Sapra et al.
CLINICAL CANCER RESEARCH (2005)
Further evidence for increased macrophage migration inhibitory factor expression in prostate cancer
KLM Siegler et al.
BMC CANCER (2005)
A gene atlas of the mouse and human protein-encoding transcriptomes
AI Su et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
CD74 is expressed by multiple myeloma and is a promising target for therapy
JD Burton et al.
CLINICAL CANCER RESEARCH (2004)
Antiproliferative activity of a humanized anti-CD74 monoclonal antibody, hLL1, on B-cell malignancies
R Stein et al.
BLOOD (2004)
Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression
D de Totero et al.
HEMATOLOGY JOURNAL (2004)
MIF signal transduction initiated by binding to CD74
L Leng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Human cathepsin S, but not cathepsin L, degrades efficiently MHC class II-associated invariant chain in nonprofessional APCs
J Bania et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Asparagine endopeptidase can initiate the removal of the MHC class II invariant chain chaperone
B Manoury et al.
IMMUNITY (2003)
Invariant chain-induced B cell differentiation requires intramembrane proteolytic release of the cytosolic domain
D Matza et al.
IMMUNITY (2002)
Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity
D Matza et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Expression of MHC class II-associated invariant chain (Ii;CD74) in thymic epithelial neoplasms
MW Datta et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2000)
分享论文
